Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology


  1. 2009
  2. Published

    Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

    Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

    Soleimani, A., Berntsen, A., Svane, Inge Marie & Pedersen, Anders Elm, 2009, In: Scandinavian Journal of Immunology. 70, 5, p. 481-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

    Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A., Hentze, J., Andresen, B., Svane, I., Gerstoft, J., Kronborg, G., Fomsgaard, A., Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A. E., Hentze, J. L., Andresen, B. S. & 4 others, Svane, I. M., Gerstoft, J., Kronborg, Gitte & Fomsgaard, A., 2009, In: AIDS. 23, 11, p. 1329-40 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

    Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag)

    Wenandy, L., Kollgaard, T., Letsch, A., Andersen, R. S., Stather, D., Seremet, T., Svane, Inge Marie, Vindeløv, L., Andersen, M. H. & thor Straten, P., 2009, In: Leukemia. 23, 10, p. 1926-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

    Sørensen, R. B., Berge-Hansen, L., Junker, N., Hansen, C. A., Hadrup, S. R., Schumacher, T. N. M., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: PLoS ONE. 4, 9, p. e6910

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

    Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: Cancer Immunology, Immunotherapy. 58, 5, p. 665-75 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2010
  10. Published

    Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

    Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  11. Published

    Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

    Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  12. Published

    Increase of Circulating CD4(+)CD25(high)Foxp3(+) Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2

    Berntsen, A., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Berntsen, A., Brimnes, M. K., Straten, P. T. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-434 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...28 Next

ID: 4054758